A Randomised, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Tdap-IPV Vaccine and a Tetanus Monovalent Vaccine in Healthy Adults 18 Years of Age and Older.
Phase of Trial: Phase III
Latest Information Update: 06 Feb 2017
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; Tetanus vaccine
- Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- Sponsors sanofi pasteur MSD
- 25 Aug 2011 New source identified and integrated (German Clinical Trials Register).
- 18 Dec 2009 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 11 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.